Inflammatory pathogenesis of prostate cancer and celecoxib. - Suppr | 超能文献

Inflammatory pathogenesis of prostate cancer and celecoxib.

作者信息

Mathew Paul

出版信息

J Clin Oncol. 2010 Apr 20;28(12):e197; author reply e198. doi: 10.1200/JCO.2009.27.1098. Epub 2010 Feb 22.

DOI:10.1200/JCO.2009.27.1098

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Inflammatory pathogenesis of prostate cancer and celecoxib.

J Clin Oncol. 2010 Apr 20;28(12):e197; author reply e198. doi: 10.1200/JCO.2009.27.1098. Epub 2010 Feb 22.

2

Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.塞来昔布用于根治性放疗或根治性前列腺切除术后前列腺特异性抗原复发的前列腺癌的II期试验。

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2172-7. doi: 10.1158/1078-0432.CCR-05-2067.

3

Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.非甾体抗炎药在转基因腺癌小鼠前列腺模型中对小鼠前列腺上皮内瘤变的消退作用

Clin Cancer Res. 2004 Nov 15;10(22):7727-37. doi: 10.1158/1078-0432.CCR-04-0732.

4

Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.塞来昔布对小鼠前列腺腺癌生长的抑制作用：参与COX - 2抑制的转录因子下调

Prostate. 2006 Feb 15;66(3):257-65. doi: 10.1002/pros.20331.

5

Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.塞来昔布在人结肠癌原位植入肿瘤模型中抑制肿瘤生长和血管生成。

Exp Oncol. 2008 Mar;30(1):42-51.

6

PSA and clinical responses to celecoxib in a patient with prostate cancer and bone metastases.一名前列腺癌伴骨转移患者的前列腺特异性抗原（PSA）及对塞来昔布的临床反应

Mayo Clin Proc. 2005 Aug;80(8):1100-1. doi: 10.4065/80.8.1100.

7

[Celecoxib inhibits gastric adenocarcinoma growth via inducing expression of human nonsteroidal anti-inflammatory drug activated gene].

Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 Nov;40(6):1029-32.

8

The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate.一项关于塞来昔布在前列腺癌临床局限性腺癌前列腺切除术前男性患者中的随机、安慰剂对照试验的设计。

Clin Prostate Cancer. 2002 Dec;1(3):182-7. doi: 10.3816/cgc.2002.n.021.

9

Cyclooxygenase-2 selective inhibitors and prostate cancer: what is the clinical benefit?环氧化酶-2 选择性抑制剂与前列腺癌：临床益处何在？

J Clin Oncol. 2006 Jun 20;24(18):2691-3. doi: 10.1200/JCO.2006.05.9709.

10

[Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].[选择性环氧化酶-2抑制剂塞来昔布术前短期治疗对胃癌组织中E-钙黏蛋白表达的影响]

Ai Zheng. 2009 Apr;28(4):361-5.

引用本文的文献

1

Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.前列腺癌的流行病学研究（EPICAP）：法国一项基于人群的病例对照研究。

BMC Cancer. 2014 Feb 19;14:106. doi: 10.1186/1471-2407-14-106.

2

Novel biodegradable porous scaffold applied to skin regeneration.新型可生物降解多孔支架在皮肤再生中的应用。

PLoS One. 2013 Jun 10;8(6):e56330. doi: 10.1371/journal.pone.0056330. Print 2013.